Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Bugs, guts and brains, and the regulation of food intake and body weight.

Hamilton MK, Raybould HE.

Int J Obes Suppl. 2016 Dec;6(Suppl 1):S8-S14. doi: 10.1038/ijosup.2016.3. Epub 2016 Nov 16. Review.

2.

Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet.

Zhang L, Andersen D, Roager HM, Bahl MI, Hansen CH, Danneskiold-Samsøe NB, Kristiansen K, Radulescu ID, Sina C, Frandsen HL, Hansen AK, Brix S, Hellgren LI, Licht TR.

Sci Rep. 2017 Mar 16;7:44613. doi: 10.1038/srep44613.

3.

Gut Microbiota and Complications of Liver Disease.

Acharya C, Bajaj JS.

Gastroenterol Clin North Am. 2017 Mar;46(1):155-169. doi: 10.1016/j.gtc.2016.09.013. Review.

PMID:
28164848
4.

Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle.

Rodriguez-Castaño GP, Caro-Quintero A, Reyes A, Lizcano F.

Front Genet. 2017 Jan 10;7:224. doi: 10.3389/fgene.2016.00224. eCollection 2016. Review.

5.

The Gastrointestinal Tract as a Key Target Organ for the Health-Promoting Effects of Dietary Proanthocyanidins.

Cires MJ, Wong X, Carrasco-Pozo C, Gotteland M.

Front Nutr. 2017 Jan 3;3:57. doi: 10.3389/fnut.2016.00057. eCollection 2016. Review.

6.

Immunologic impact of the intestine in metabolic disease.

Winer DA, Winer S, Dranse HJ, Lam TK.

J Clin Invest. 2017 Jan 3;127(1):33-42. doi: 10.1172/JCI88879. Epub 2017 Jan 3.

7.

The role of dietary fat in obesity-induced insulin resistance.

Lackey DE, Lazaro RG, Li P, Johnson A, Hernandez-Carretero A, Weber N, Vorobyova I, Tsukomoto H, Osborn O.

Am J Physiol Endocrinol Metab. 2016 Dec 1;311(6):E989-E997. doi: 10.1152/ajpendo.00323.2016. Epub 2016 Nov 1.

PMID:
27802965
8.
9.

Gut microbiota and immune crosstalk in metabolic disease.

Burcelin R.

Mol Metab. 2016 Jun 6;5(9):771-81. doi: 10.1016/j.molmet.2016.05.016. eCollection 2016 Sep. Review.

10.

Macrophage alterations within the mesenteric lymphatic tissue are associated with impairment of lymphatic pump in metabolic syndrome.

Zawieja SD, Wang W, Chakraborty S, Zawieja DC, Muthuchamy M.

Microcirculation. 2016 Oct;23(7):558-570. doi: 10.1111/micc.12307.

PMID:
27588380
11.

The intestinal microbiome and surgical disease.

Krezalek MA, Skowron KB, Guyton KL, Shakhsheer B, Hyoju S, Alverdy JC.

Curr Probl Surg. 2016 Jun;53(6):257-93. doi: 10.1067/j.cpsurg.2016.06.001. Epub 2016 Jun 14. Review. No abstract available.

12.

Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Sato H, Zhang LS, Martinez K, Chang EB, Yang Q, Wang F, Howles PN, Hokari R, Miura S, Tso P.

Gastroenterology. 2016 Nov;151(5):923-932. doi: 10.1053/j.gastro.2016.07.009. Epub 2016 Jul 18.

13.

Endotoxemia-menace, marker, or mistake?

Munford RS.

J Leukoc Biol. 2016 Oct;100(4):687-698. Epub 2016 Jul 14. Review.

PMID:
27418356
14.

Impact of the gut microbiota on inflammation, obesity, and metabolic disease.

Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME.

Genome Med. 2016 Apr 20;8(1):42. doi: 10.1186/s13073-016-0303-2. Review.

15.

Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Fawley J, Gourlay DM.

J Surg Res. 2016 May 1;202(1):225-34. doi: 10.1016/j.jss.2015.12.008. Epub 2015 Dec 17. Review.

16.

Mechanisms Linking the Gut Microbiome and Glucose Metabolism.

Utzschneider KM, Kratz M, Damman CJ, Hullarg M.

J Clin Endocrinol Metab. 2016 Apr;101(4):1445-54. doi: 10.1210/jc.2015-4251. Epub 2016 Mar 3. Review.

17.

Probiotics in prevention and treatment of obesity: a critical view.

Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, Fusek J, Rodrigo L, Kruzliak P.

Nutr Metab (Lond). 2016 Feb 20;13:14. doi: 10.1186/s12986-016-0067-0. eCollection 2016. Review.

18.

Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?

Brahe LK, Astrup A, Larsen LH.

Adv Nutr. 2016 Jan 15;7(1):90-101. doi: 10.3945/an.115.010587. Print 2016 Jan. Review.

19.

Risks associated with endotoxins in feed additives produced by fermentation.

Wallace RJ, Gropp J, Dierick N, Costa LG, Martelli G, Brantom PG, Bampidis V, Renshaw DW, Leng L.

Environ Health. 2016 Jan 15;15:5. doi: 10.1186/s12940-016-0087-2. Review.

20.

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?

Lytle KA, Jump DB.

PLoS One. 2016 Jan 13;11(1):e0146942. doi: 10.1371/journal.pone.0146942. eCollection 2016.

Supplemental Content

Support Center